Stockwatch: Over-reaction Reigns At Rigel And Biogen
Executive Summary
Rigel and Biogen both released data last week that prompted over-reactions and sensationalism, respectively from analysts, the print media and even the BBC. When something sounds too good to be true, is probably is.